Kerstin Heurling
Kerstin Heurling
University of Gothenburg
Verified email at
Cited by
Cited by
[18F] flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer's disease: specific detection of advanced phases of amyloid-β pathology
DR Thal, TG Beach, M Zanette, K Heurling, A Chakrabarty, A Ismail, ...
Alzheimer's & Dementia 11 (8), 975-985, 2015
Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection
MD Ikonomovic, CJ Buckley, K Heurling, P Sherwin, PA Jones, M Zanette, ...
Acta neuropathologica communications 4 (1), 130, 2016
Positron emission tomography with [18F]flutemetamol and [11C]PiB for in vivo detection of cerebral cortical amyloid in normal pressure hydrocephalus patients
V Leinonen, JO Rinne, KA Virtanen, O Eskola, J Rummukainen, ...
European Journal of Neurology 20 (7), 1043-1052, 2013
Overeating saturated fat promotes fatty liver and ceramides compared with polyunsaturated fat: a randomized trial
F Rosqvist, J Kullberg, M Ståhlman, J Cedernaes, K Heurling, ...
The Journal of Clinical Endocrinology & Metabolism 104 (12), 6207-6219, 2019
Use of amyloid PET across the spectrum of Alzheimer’s disease: clinical utility and associated ethical issues
A Leuzy, ER Zimmer, K Heurling, P Rosa-Neto, S Gauthier
Amyloid 21 (3), 143-148, 2014
Imaging β-amyloid using [18F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosis
K Heurling, A Leuzy, ER Zimmer, M Lubberink, A Nordberg
European journal of nuclear medicine and molecular imaging 43 (2), 362-373, 2016
Quantitative positron emission tomography in brain research
K Heurling, A Leuzy, M Jonasson, A Frick, ER Zimmer, A Nordberg, ...
Brain research 1670, 220-234, 2017
Update on biomarkers for amyloid pathology in Alzheimer's disease
NJ Ashton, M Schöll, K Heurling, E Gkanatsiou, E Portelius, K Höglund, ...
Biomarkers in medicine 12 (7), 799-812, 2018
Serotonin synthesis rate and the tryptophan hydroxylase-2: G-703T polymorphism in social anxiety disorder
T Furmark, I Marteinsdottir, A Frick, K Heurling, M Tillfors, L Appel, ...
Journal of Psychopharmacology 30 (10), 1028-1035, 2016
Whole-body imaging of tissue-specific insulin sensitivity and body composition by using an integrated PET/MR system: a feasibility study
E Johansson, M Lubberink, K Heurling, JW Eriksson, S Skrtic, H Ahlström, ...
Radiology 286 (1), 271-278, 2018
Diagnostic effectiveness of quantitative [18F]flutemetamol PET imaging for detection of fibrillar amyloid β using cortical biopsy histopathology as the standard of …
V Leinonen, JO Rinne, DF Wong, DA Wolk, JQ Trojanowski, PF Sherwin, ...
Acta neuropathologica communications 2 (1), 46, 2014
Parametric imaging and quantitative analysis of the PET amyloid ligand [18F] flutemetamol
K Heurling, C Buckley, K Van Laere, R Vandenberghe, M Lubberink
Neuroimage 121, 184-192, 2015
Altered glucose uptake in muscle, visceral adipose tissue, and brain predict whole-body insulin resistance and may contribute to the development of type 2 diabetes: a combined …
GJ Boersma, E Johansson, MJ Pereira, K Heurling, S Skrtic, J Lau, ...
Hormone and Metabolic Research 50 (08), 627-639, 2018
Synaptic vesicle protein 2A as a potential biomarker in synaptopathies
K Heurling, NJ Ashton, A Leuzy, ER Zimmer, K Blennow, H Zetterberg, ...
Molecular and Cellular Neuroscience 97, 34-42, 2019
Focus: Medical Technology: In vivo Detection of Alzheimer’s Disease
A Leuzy, K Heurling, NJ Ashton, M Schöll, ER Zimmer
The Yale journal of biology and medicine 91 (3), 291, 2018
BL-1020, a novel antipsychotic candidate with GABA-enhancing effects: D2 receptor occupancy study in humans
L Appel, Y Geffen, K Heurling, C Eriksson, G Antoni, S Kapur
European Neuropsychopharmacology 19 (12), 841-850, 2009
Estimation of amyloid distribution by [18F]flutemetamol PET predicts the neuropathological phase of amyloid β-protein deposition
DR Thal, TG Beach, M Zanette, J Lilja, K Heurling, A Chakrabarty, A Ismail, ...
Acta neuropathologica 136 (4), 557-567, 2018
Separation of β-amyloid binding and white matter uptake of 18F-flutemetamol using spectral analysis
K Heurling, C Buckley, R Vandenberghe, K Van Laere, M Lubberink
American journal of nuclear medicine and molecular imaging 5 (5), 515, 2015
Brain uptake and safety of Flutemetamol F 18 injection in Japanese subjects with probable Alzheimer’s disease, subjects with amnestic mild cognitive impairment and healthy …
T Miki, H Shimada, JS Kim, Y Yamamoto, M Sugino, H Kowa, K Heurling, ...
Annals of nuclear medicine 31 (3), 260-272, 2017
O1‐04‐02: Flutemetamol F 18 injection PET images reflect brain beta‐amyloid levels
C Buckley, M Ikonomovic, A Smith, K Heurling, G Farrar, D Brooks, ...
Alzheimer's & Dementia 8 (4S_Part_3), P90-P90, 2012
The system can't perform the operation now. Try again later.
Articles 1–20